Dermatology Editors' Choice: Top Stories of 2013

Letter to Readers |
December 27, 2013

Dermatology Editors' Choice: Top Stories of 2013

  1. Hensin Tsao, MD, PhD

A perspective on the most important research in the field from the past year

  1. Hensin Tsao, MD, PhD

Although our government came to a grinding halt this year, I am glad to report that our editorial board has been busier than ever. Our choices of the most interesting and important dermatology stories of the past year are listed below. 2013 has been a banner year for all things therapeutic. In particular, we are witnessing an infusion of molecular medicine research: the use of targeted immune therapy in melanoma, the identification of genetic markers for predicting anti-TNF response in psoriasis, and the recognition of atypical protein kinase as a new therapeutic target in basal cell carcinoma. We also witnessed the value of consensus-based practices, such as propranolol treatment for infantile hemangioma. In some ways, these stories reflect trends in medicine overall. The pace of science is creating novel therapies at a dizzying pace, while the cost of medicine is forcing us to make the best choices based on evidence.

This has been an exciting year for us, as we embraced a broader collaboration with our colleagues in the NEJM Group and changed our name to NEJM Journal Watch Dermatology. We remain devoted to providing clinicians with the information they need to give their patients the best care — and, as part of NEJM Group, we are now poised to do so more effectively than ever. Our NEJM Journal Watch Dermatology editors will continue to pursue our goal of interpreting the latest research for application to clinical practice and reporting on science that will affect practice in the future. I hope you enjoy this Top Ten list.

Our Dermatology Top Stories of 2013 are:

The Use of Propranolol for Infantile Hemangioma: Consensus Recommendations

Adalimumab a “Proven” Therapy for Hidradenitis Suppurativa

Prophylaxis for Leg Cellulitis

Combined Immune Checkpoint Therapies Impressive in Advanced Melanoma

Genetic Markers That Identify TNF-Inhibitor Responders in Psoriasis

Cutaneous T-Cell Lymphoma and Defective Apoptosis: Fas Pathway

Chasing the Hedgehog: aPKC as a Potential Target in BCC

Risk for Metastasis and Death from Cutaneous Squamous Cell Carcinoma

Omalizumab Effectively Controls Chronic Idiopathic or Spontaneous Urticaria

Calcium-Channel Blockers and Chronic Eczematous Eruptions of the Aged

Happy New Year!

Editor Disclosures at Time of Publication

  • Disclosures for Hensin Tsao, MD, PhD at time of publication Consultant / advisory board Genentech; Quest Diagnostics; WorldCare Clinical Grant / research support NIH; Department of Defense; American Skin Association Editorial boards British Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)

Reader Comments (4)

Rosibel Morales Physician, Internal Medicine, CMRC ALAJUELA Costa Rica

Este método de aprendizaje será de ayuda especial enmi diario actuar como medico

Rosibel Morales CMRC ALAJUELA Costa Rica

Este sistema es excelente para adquirir mejores conocimientos

Raul Alberto Ruiz Mora Other, Other

Specialty: stomatology

Elizabeth Parada Physician, Allergy/Immunology, hospital Luis Razetti

Espero poder recibir importante informacion para mis estudiantes y para la practica medica

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.